Targeting Macrophages for Enhancing CD47 Blockade-Elicited Lymphoma Clearance and Overcoming Tumor-Induced Suppression

The authors showed that late-stage Non-Hodgkin’s Lymphoma was resistant to therapy targeting phagocytosis checkpoint CD47, due to the compromised capacity of tumor-associated macrophages to phagocytose lymphoma cells.